NDC product
CAPSULE · Lilly del Caribe, Inc.
NDC 0110-3250 · Lilly del Caribe, Inc.
Key facts
| Product NDC | 0110-3250 |
|---|---|
| Nonproprietary name | Atomoxetine hydrochloride |
| Substances | ATOMOXETINE HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Labeler | Lilly del Caribe, Inc. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Feb 14, 2005 |
| Marketing end | Jul 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory